Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn:
“Are you already planning your 2026 strategy in precision oncology?
If you’re working on:
- Market Access Strategy or Reimbursement Pathways
- Biomarker / Diagnostic Implementation across Europe
- KOL & Stakeholder Engagement Planning
…then I would love to connect.
I’ll be at ESMO25 (17–20 Oct) and keeping my schedule open for 30-minute strategy conversations with diagnostic and oncology leaders.
Book a meeting with me during ESMO
Not attending? No problem.
You can still grab a 20-minute free consultation here.
Looking forward leaving my home-office and actually seeing in person many of you next week in Berlin!.”
Read more posts featuring ESMO 2025 on OncoDaily.
